Effectiveness of a Single Chair Side Application of NovaMin<sup>®</sup> [Calcium Sodium Phosphosilicate] in the Treatment of Dentine Hypersensitivity following Ultrasonic Scaling—A Randomized Controlled Trial
Jeeth Janardhan Rai,
Saurabh Chaturvedi,
Shankar T. Gokhale,
Raghavendra Reddy Nagate,
Saad M. Al-Qahtani,
Mohammad Al. Magbol,
Shashit Shetty Bavabeedu,
Mohamed Fadul A. Elagib,
Vatsala Venkataram,
Mudita Chaturvedi
Affiliations
Jeeth Janardhan Rai
Department of Periodontology, Bharati Vidyapeeth Dental College and Hospital, Sangli 416406, Maharastra, India
Saurabh Chaturvedi
Department of Prosthetic Dentistry, College of Dentistry, King Khalid University, Abha 61421, Saudi Arabia
Shankar T. Gokhale
Department of Periodontics and Community Dental Sciences, College of Dentistry, King Khalid University, Abha 61421, Saudi Arabia
Raghavendra Reddy Nagate
Department of Periodontics and Community Dental Sciences, College of Dentistry, King Khalid University, Abha 61421, Saudi Arabia
Saad M. Al-Qahtani
Department of Periodontics and Community Dental Sciences, College of Dentistry, King Khalid University, Abha 61421, Saudi Arabia
Mohammad Al. Magbol
Department of Periodontics and Community Dental Sciences, College of Dentistry, King Khalid University, Abha 61421, Saudi Arabia
Shashit Shetty Bavabeedu
Restorative Dental Sciences, College of Dentistry, King Khalid University, Abha 61421, Saudi Arabia
Mohamed Fadul A. Elagib
Department of Periodontics and Community Dental Sciences, College of Dentistry, King Khalid University, Abha 61421, Saudi Arabia
Vatsala Venkataram
Department of Pedodontics & Preventive Dentistry, KVG Dental College & Hospital, Sullia 574327, Karnataka, India
Mudita Chaturvedi
Independent Researcher, Bhopal 462008, Madhya Pradesh, India
Dentinal hypersensitivity or cervical dentinal sensitivity is one of the commonest clinical problems. The aim of this randomized controlled trial was to evaluate the effectiveness of a single chair side application of 100% pure calcium sodium phosphosilicate (NovaMin®) in reducing dentin hypersensitivity following ultrasonic scaling as evaluated on a visual analogue scale (VAS). The study included 50 subjects who were selected based on an evaluation of dentinal hypersensitivity on a VAS carried out using a metered air blast from a three-way syringe and divided into two groups (n = 25/group); i.e., the test group (Group A) received the NovaMin® paste and the control group (Group B) received a placebo paste made from pumice. All the 50 subjects included in the study were had VAS scores of 3 or more. The NovaMin® powder mixed with distilled water was applied. Dentinal hypersensitivity was reassessed immediately and after 1, 2 and 4 weeks after the procedure. Results showed that the percentage reduction of dentinal hypersensitivity following a single application of NovaMin® in powder form was about 76.38% immediately, 67.72% one week postoperatively, 52.76% two weeks postoperatively and 26.78% four weeks postoperatively. It can be concluded from the results of the current clinical study demonstrated that a single chair side application of NovaMin® in powder form has a significant and immediate reduction in dentinal hypersensitivity, which lasted nearly for four weeks.
